Publications by authors named "Alexander Matthies"

Claim this Profile
A
A previously unknown Argonaute 2 variant positively modulates the viability of melanoma cells.
Lisa Linck-Paulus, Tina Meißgeier, Katharina Pieger, Anselm H C Horn, Alexander Matthies

Cell Mol Life Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of Lamin B1 and the Corresponding Lamin B Receptor Leads to Changes in Heterochromatin State and Senescence Induction in Malignant Melanoma.
Lisa Lämmerhirt, Melanie Kappelmann-Fenzl, Stefan Fischer, Michaela Pommer, Tom Zimmermann, Alexander Matthies

Cells· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma.
Markus V Heppt, Anja Wessely, Eva Hornig, Claudia Kammerbauer, Saskia A Graf, Alexander Matthies

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Changes Induced in Melanoma by Cell Culturing in 3D Alginate Hydrogels.
Melanie Kappelmann-Fenzl, Sonja K Schmidt, Stefan Fischer, Rafael Schmid, Lisa Lämmerhirt, Alexander Matthies

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Jun drives melanoma progression in PTEN wild type melanoma cells.
Melanie Kappelmann-Fenzl, Claudia Gebhard, Alexander O Matthies, Silke Kuphal, Michael Rehli

Cell Death Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cells Are Dispensable for T Cell Priming and Control of Acute Lymphocytic Choriomeningitis Virus Infection.
Cornelia Hilpert, Selina Sitte, Alexander Matthies, David Voehringer

J Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG.
Samer Ezziddin, Amir Sabet, Yon-Dschun Ko, Sunny Xun, Alexander Matthies

Radiat Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Michael J Reinhardt, Alexius Y Joe, Ursula Jaeger, Andrea Huber, Alexander Matthies

J Clin Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.
Michael J Reinhardt, Nicole Wiethoelter, Alexander Matthies, Alexius Y Joe, Holger Strunk

Eur J Nucl Med Mol Imaging· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Alexander Matthies, M Reinhardt, H Palmedo, S Ezziddin, B Abramowski

Cancer Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Claudia Heuser, Stefan Guhlke, Alexander Matthies, Hans Bender, Stefan Barth

Int J Cancer· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT.
Alexander Matthies, Samer Ezziddin, Eva-Maria Ulrich, Holger Palmedo, Hans-Jürgen Biersack

Eur J Nucl Med Mol Imaging· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone scintigraphy of Raynaud's syndrome secondary to fibromuscular dysplasia.
Alexander Matthies, Susanne Meyka, Hans-Jürgen Biersack, Michael Reinhardt

Clin Nucl Med· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Robert M Sharkey, Arnold Brenner, Jack Burton, George Hajjar, Stephen P Toder, Alexander Matthies

J Nucl Med· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
Marc Hickeson, Mijin Yun, Alexander Matthies, Hongming Zhuang, Lars-Eric Adam

Eur J Nucl Med Mol Imaging· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Holger Palmedo, Jenne Hensel, Michael Reinhardt, Dirk Von Mallek, Alexander Matthies

Nucl Med Biol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Alexander Matthies, Marc Hickeson, Andrew Cuchiara, Abass Alavi

J Nucl Med· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer.
George Hajjar, Robert M Sharkey, Jack Burton, Chu-Hui Zhang, Dion Yeldell, Alexander Matthies

Clin Colorectal Cancer· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis